TMAO and HIV-Associated Atherosclerosis

Adjusted (95% CI), p-value Age (per decade) 37% (9%, 71%), p = 0.007 34% (12%, 60%), p = 0.001 Male 14% (-41%, 118%), p = 0.70 16% (-36%, 11%), p = 0.62 -25% (-51%, 15%), p = 0.19 8% (-36%, 83%), p = 0.78 Latino -47% (-58%, -32%), p = 0.00 -19% (-52%, 38%), p = 0.44 Other 214% (-25%, 1224%), p = 0.12 161% (-7%, 629%), p = 0.07 Diabetes -29% (-53%, 7%), p = 0.11 -21% (-42%, 7%), p = 0.13 Current Smoking 59% (-9%, 177%), p = 0.10 61% (9%, 136%), p = 0.02 HDL (per 10 mg/dL) -13% (-27%, 3%), p = 0.10 -6% (-15%, 5%), p = 0.28 Triglycerides (per 10 mg/dL) 2% (1%, 3%), p = 0.00 1% (1%, 2%), p = 0.001 Current ARV Use 78% (22%, 162%), p = 0.003 58% (5%, 138%), p = 0.03 HIV RNA >75 copies/mL -20% (-37%, 20%), p = 0.28 6% (-45%, 104%), p = 0.86